Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC, 37520-37524 [2018-16468]
Download as PDF
<![CDATA[
37520
Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices
with either or both of these definitions,
please explain why and provide
alternative definitions.
Authority: This proceeding is being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to section 207.61 of the
Commission’s rules.
By order of the Commission.
Issued: July 27, 2018.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2018–16435 Filed 7–31–18; 8:45 am]
BILLING CODE 7020–02–P
collection instrument with instructions,
or desire any other additional
information, please contact Erica Payne,
National Firearms Act Division, either
by mail at 244 Needy Road,
Martinsburg, WV 25405, by email at
Erica.payne@atf.gov or by telephone at
304–616–4582. Written comments and/
or suggestions can also be directed to
the Office of Management and Budget,
Office of Information and Regulatory
Affairs, Attention Department of Justice
Desk Officer, Washington, DC 20503 or
sent to OIRA_submissions@
omb.eop.gov.
Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF JUSTICE
Bureau of Alcohol, Tobacco, Firearms
and Explosives
[OMB Number 1140–0101]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; National
Firearms Act Division and Firearms
and Explosives Services Division
Customer Service Survey
Bureau of Alcohol, Tobacco,
Firearms and Explosives, Department of
Justice.
ACTION: 30-day notice.
AGENCY:
The Department of Justice
(DOJ), Bureau of Alcohol, Tobacco,
Firearms and Explosives (ATF), will
submit the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995. A
minor change is being made to the
proposed collection OMB 1140–0101
(Firearms and Explosives Services
Division (FESD) Customer Service
Survey), to include references to the
recently established National Firearms
Act Division (NFA Division); which was
previously a branch in FESD. All survey
questions directly relate to customer
experience in FESD, NFA Division and
their branches. The proposed collection
is being published to obtain comments
from the public and affected agencies.
The proposed information collection
was previously published in the Federal
Register, on May 30, 2018, allowing for
a 60-day comment period.
DATES: Comments are encouraged and
will be accepted for an additional 30
days until August 31, 2018.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments,
particularly with respect to the
estimated public burden or associated
response time, have suggestions, need a
copy of the proposed information
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:07 Jul 31, 2018
Jkt 244001
Overview of This Information
Collection
(1) Type of Information Collection:
Extension, with change, of a currently
approved collection.
(2) The Title of the Form/Collection:
National Firearms Act Division and
Firearms and Explosives Services
Division Customer Service Survey.
(3) The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form number: None.
Component: Bureau of Alcohol,
Tobacco, Firearms and Explosives, U.S.
Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Other: Individuals or Households,
Federal Government, and State, Local,
or Tribal Government.
Abstract: The purpose of this survey
is to gather information about customer
service provided to the firearms and
explosives industry and government
agencies, in order to improve service
delivery and customer satisfaction.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 18,200
respondents will utilize this survey, and
it will take each respondent
approximately 5 minutes to complete
their responses.
(6) An estimate of the total public
burden (in hours) associated with the
collection: The estimated annual public
burden associated with this collection is
1,517 hours which is equal to: 18,200
(total # of responses) * .0833333 (5
minutes).
If additional information is required
contact: Melody Braswell, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 3E.405A,
Washington, DC 20530.
Date: July 27, 2018.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2018–16487 Filed 7–31–18; 8:45 am]
BILLING CODE 4410–14–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Chemtos,
LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 1, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
DATES:
E:\FR\FM\01AUN1.SGM
01AUN1
37521
Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
delegated to the Assistant Administrator
of the DEA Diversion Control Division
(‘‘Assistant Administrator’’) pursuant to
section 7 of 28 CFR part 0, appendix to
subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on June
11, 2018, Chemtos, LLC, 14101 West
Highway 290, Building 2000B, Austin,
Texas 78737 applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
sradovich on DSK3GMQ082PROD with NOTICES
Controlled substance
Drug code
3-Fluoro-N-methylcathinone (3–FMC) .....................................................................................................................
Cathinone .................................................................................................................................................................
Methcathinone .........................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) .....................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...........................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) .......................................................................................................................
Naphyrone ...............................................................................................................................................................
N-Ethylamphetamine ...............................................................................................................................................
N,N-Dimethylamphetamine ......................................................................................................................................
Fenethylline ..............................................................................................................................................................
Aminorex ..................................................................................................................................................................
4-Methylaminorex (cis isomer) ................................................................................................................................
Gamma Hydroxybutyric Acid ...................................................................................................................................
Methaqualone ..........................................................................................................................................................
Mecloqualone ...........................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ..........................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ........................................
ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .....
5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ........
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .............
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ..............................................................................................................
MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ..............
AB–PINACA (N-(1-amino-3-methyl- ........................................................................................................................
1-oxobutan-2-yl)-1-pentyl-1H-indazole- ...................................................................................................................
3-carboxamide) ........................................................................................................................................................
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3- ............................................................................................................
yl](naphthalen-1-yl)methanone ................................................................................................................................
AB–CHMINACA (N-(1-amino-3-methyl-1- ...............................................................................................................
oxobutan-2-yl)-1-(cyclohexylmethyl)- .......................................................................................................................
1H-indazole-3-carboxamide .....................................................................................................................................
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)
5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ......................................
5F–ADB;
5F–MDMB–PINACA
(Methyl
2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3dimethylbutanoate) ...............................................................................................................................................
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .........................
MDMB–CHMICA,
MMB–CHMINACA
(Methyl
2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3dimethylbutanoate) ...............................................................................................................................................
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .......................................................
5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ...........................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ..........................................................................................
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ............................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ......................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) .............................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .........................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ...............................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ..................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ...............................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ..............................................................................................
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .........................................................................................
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ....................................................................
Alpha-ethyltryptamine ..............................................................................................................................................
Ibogaine ...................................................................................................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) .........................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ...................................
Lysergic acid diethylamide ......................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) ......................................................................................
Marihuana Extract ....................................................................................................................................................
Marihuana ................................................................................................................................................................
Parahexyl .................................................................................................................................................................
Mescaline .................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2 ) ..................................................................................
3,4,5-Trimethoxyamphetamine ................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine ......................................................................................................................
VerDate Sep<11>2014
20:07 Jul 31, 2018
Jkt 244001
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
E:\FR\FM\01AUN1.SGM
01AUN1
Schedule
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1503
1585
1590
2010
2565
2572
6250
7008
7010
7011
7012
7019
7020
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7023
I
7024
I
7031
7032
7033
I
I
I
7034
7035
I
I
7042
7048
7049
7081
7104
7118
7122
7144
7173
7200
7201
7203
7222
7225
7249
7260
7297
7298
7315
7348
7350
7360
7374
7381
7385
7390
7391
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
37522
Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
Controlled substance
Drug code
4-Bromo-2,5-dimethoxyphenethylamine ..................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine ......................................................................................................................
2,5-Dimethoxyamphetamine ....................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ..............................................................................................
2,5-Dimethoxy-4-ethylamphetamine ........................................................................................................................
3,4-Methylenedioxyamphetamine ............................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..........................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..........................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ...............................................................................................................
3,4-Methylenedioxymethamphetamine ....................................................................................................................
4-Methoxyamphetamine ..........................................................................................................................................
5-Methoxy-N–N-dimethyltryptamine ........................................................................................................................
Alpha-methyltryptamine ...........................................................................................................................................
Bufotenine ................................................................................................................................................................
Diethyltryptamine .....................................................................................................................................................
Dimethyltryptamine ..................................................................................................................................................
Psilocybin .................................................................................................................................................................
Psilocyn ....................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine ......................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ............................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ............................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .......................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ......................................................................................................................
N-Ethyl-3-piperidyl benzilate ....................................................................................................................................
N-Methyl-3-piperidyl benzilate .................................................................................................................................
N-Benzylpiperazine ..................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ..............................................................................................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) ..........................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) ............................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) .........................................................................................................
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) ..........................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) ............................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) .....................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4 ) ...........................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ...............................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) ............................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) ............................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) .................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ..............................................................................................
Butylone ...................................................................................................................................................................
Pentylone .................................................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ..................................................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ...........................................................................................
Acetyldihydrocodeine ...............................................................................................................................................
Benzylmorphine .......................................................................................................................................................
Codeine-N-oxide ......................................................................................................................................................
Cyprenorphine .........................................................................................................................................................
Desomorphine ..........................................................................................................................................................
Etorphine (except HCl) ............................................................................................................................................
Codeine methylbromide ...........................................................................................................................................
Dihydromorphine ......................................................................................................................................................
Difenoxin ..................................................................................................................................................................
Heroin ......................................................................................................................................................................
Hydromorphinol ........................................................................................................................................................
Methyldesorphine .....................................................................................................................................................
Methyldihydromorphine ............................................................................................................................................
Morphine methylbromide .........................................................................................................................................
Morphine methylsulfonate ........................................................................................................................................
Morphine-N-oxide ....................................................................................................................................................
Myrophine ................................................................................................................................................................
Nicocodeine .............................................................................................................................................................
Nicomorphine ...........................................................................................................................................................
Normorphine ............................................................................................................................................................
Pholcodine ...............................................................................................................................................................
Thebacon .................................................................................................................................................................
Acetorphine ..............................................................................................................................................................
Drotebanol ...............................................................................................................................................................
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ......................................................
AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ..........................................................
Acetylmethadol ........................................................................................................................................................
Allylprodine ..............................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ..............................................................................................
VerDate Sep<11>2014
20:07 Jul 31, 2018
Jkt 244001
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
E:\FR\FM\01AUN1.SGM
01AUN1
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7455
7458
7470
7473
7482
7484
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7545
7546
7694
9051
9052
9053
9054
9055
9056
9070
9145
9168
9200
9301
9302
9304
9305
9306
9307
9308
9309
9312
9313
9314
9315
9319
9335
9547
9551
9601
9602
9603
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
37523
Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
Controlled substance
Drug code
Alphameprodine .......................................................................................................................................................
Alphamethadol .........................................................................................................................................................
Benzethidine ............................................................................................................................................................
Betacetylmethadol ...................................................................................................................................................
Betameprodine .........................................................................................................................................................
Betamethadol ...........................................................................................................................................................
Betaprodine ..............................................................................................................................................................
Clonitazene ..............................................................................................................................................................
Dextromoramide ......................................................................................................................................................
Diampromide ............................................................................................................................................................
Diethylthiambutene ..................................................................................................................................................
Dimenoxadol ............................................................................................................................................................
Dimepheptanol .........................................................................................................................................................
Dimethylthiambutene ...............................................................................................................................................
Dioxaphetyl butyrate ................................................................................................................................................
Dipipanone ...............................................................................................................................................................
Ethylmethylthiambutene ...........................................................................................................................................
Etonitazene ..............................................................................................................................................................
Etoxeridine ...............................................................................................................................................................
Furethidine ...............................................................................................................................................................
Hydroxypethidine .....................................................................................................................................................
Ketobemidone ..........................................................................................................................................................
Levomoramide .........................................................................................................................................................
Levophenacylmorphan .............................................................................................................................................
Morpheridine ............................................................................................................................................................
Noracymethadol .......................................................................................................................................................
Norlevorphanol .........................................................................................................................................................
Normethadone .........................................................................................................................................................
Norpipanone ............................................................................................................................................................
Phenadoxone ...........................................................................................................................................................
Phenampromide .......................................................................................................................................................
Phenoperidine ..........................................................................................................................................................
Piritramide ................................................................................................................................................................
Proheptazine ............................................................................................................................................................
Properidine ...............................................................................................................................................................
Racemoramide .........................................................................................................................................................
Trimeperidine ...........................................................................................................................................................
Phenomorphan ........................................................................................................................................................
Propiram ..................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ...............................................................................................................
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ......................................................................................................
Tilidine ......................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .........................................................................
Para-Fluorofentanyl .................................................................................................................................................
3-Methylfentanyl .......................................................................................................................................................
Alpha-methylfentanyl ...............................................................................................................................................
Acetyl-alpha-methylfentanyl .....................................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) .......................................................................
Butyryl Fentanyl .......................................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) .................................
Beta-hydroxyfentanyl ...............................................................................................................................................
Beta-hydroxy-3-methylfentanyl ................................................................................................................................
Alpha-methylthiofentanyl ..........................................................................................................................................
3-Methylthiofentanyl .................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .....................................................
Thiofentanyl .............................................................................................................................................................
Beta-hydroxythiofentanyl .........................................................................................................................................
Amphetamine ...........................................................................................................................................................
Methamphetamine ...................................................................................................................................................
Lisdexamfetamine ....................................................................................................................................................
Phenmetrazine .........................................................................................................................................................
Methylphenidate .......................................................................................................................................................
Amobarbital ..............................................................................................................................................................
Pentobarbital ............................................................................................................................................................
Secobarbital .............................................................................................................................................................
Glutethimide .............................................................................................................................................................
Nabilone ...................................................................................................................................................................
1-Phenylcyclohexylamine ........................................................................................................................................
Phencyclidine ...........................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .............................................................................................................
Phenylacetone .........................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ........................................................................................................................
Alphaprodine ............................................................................................................................................................
Anileridine ................................................................................................................................................................
VerDate Sep<11>2014
20:07 Jul 31, 2018
Jkt 244001
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
E:\FR\FM\01AUN1.SGM
01AUN1
9604
9605
9606
9607
9608
9609
9611
9612
9613
9615
9616
9617
9618
9619
9621
9622
9623
9624
9625
9626
9627
9628
9629
9631
9632
9633
9634
9635
9636
9637
9638
9641
9642
9643
9644
9645
9646
9647
9649
9661
9663
9750
9811
9812
9813
9814
9815
9821
9822
9824
9830
9831
9832
9833
9834
9835
9836
1100
1105
1205
1631
1724
2125
2270
2315
2550
7379
7460
7471
8333
8501
8603
9010
9020
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
37524
Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices
Controlled substance
Drug code
Cocaine ....................................................................................................................................................................
Codeine ....................................................................................................................................................................
Etorphine HCl ..........................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................
Oxycodone ...............................................................................................................................................................
Hydromorphone .......................................................................................................................................................
Diphenoxylate ..........................................................................................................................................................
Ecgonine ..................................................................................................................................................................
Ethylmorphine ..........................................................................................................................................................
Hydrocodone ............................................................................................................................................................
Levomethorphan ......................................................................................................................................................
Levorphanol .............................................................................................................................................................
Isomethadone ..........................................................................................................................................................
Meperidine ...............................................................................................................................................................
Meperidine intermediate-A .......................................................................................................................................
Meperidine intermediate-B .......................................................................................................................................
Meperidine intermediate-C ......................................................................................................................................
Methadone ...............................................................................................................................................................
Methadone intermediate ..........................................................................................................................................
Metopon ...................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ......................................................................................................
Morphine ..................................................................................................................................................................
Thebaine ..................................................................................................................................................................
Dihydroetorphine ......................................................................................................................................................
Levo-alphacetylmethadol .........................................................................................................................................
Oxymorphone ..........................................................................................................................................................
Noroxymorphone .....................................................................................................................................................
Phenazocine ............................................................................................................................................................
Thiafentanil ..............................................................................................................................................................
Piminodine ...............................................................................................................................................................
Racemethorphan .....................................................................................................................................................
Racemorphan ..........................................................................................................................................................
Alfentanil ..................................................................................................................................................................
Remifentanil .............................................................................................................................................................
Sufentanil .................................................................................................................................................................
Carfentanil ................................................................................................................................................................
Tapentadol ...............................................................................................................................................................
Bezitramide ..............................................................................................................................................................
Fentanyl ...................................................................................................................................................................
Moramide-intermediate ............................................................................................................................................
The company plans to manufacture
small quantities of the listed controlled
substances in bulk for distribution to its
customers.
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before August 31,
2018.
Dated: July 23, 2018.
John J. Martin,
Assistant Administrator.
ADDRESSES:
[FR Doc. 2018–16468 Filed 7–31–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
sradovich on DSK3GMQ082PROD with NOTICES
Importer of Controlled Substances
Application: Cody Laboratories Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before August 31, 2018. Such persons
DATES:
VerDate Sep<11>2014
20:07 Jul 31, 2018
Jkt 244001
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and request for hearing on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
9041
9050
9059
9120
9143
9150
9170
9180
9190
9193
9210
9220
9226
9230
9232
9233
9234
9250
9254
9260
9273
9300
9333
9334
9648
9652
9668
9715
9729
9730
9732
9733
9737
9739
9740
9743
9780
9800
9801
9802
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on June
20, 2018, Cody Laboratories, Inc., Steve
Hartman, 601 Yellowstone Avenue,
Cody, Wyoming 82414–9221 applied to
be registered as an importer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\01AUN1.SGM
01AUN1
]]>Agencies
[Federal Register Volume 83, Number 148 (Wednesday, August 1, 2018)]
[Notices]
[Pages 37520-37524]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16468]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Chemtos,
LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before October 1, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration
[[Page 37521]]
(DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions
with respect to the promulgation and implementation of 21 CFR part
1301, incident to the registration of manufacturers, distributors,
dispensers, importers, and exporters of controlled substances (other
than final orders in connection with suspension, denial, or revocation
of registration) has been delegated to the Assistant Administrator of
the DEA Diversion Control Division (``Assistant Administrator'')
pursuant to section 7 of 28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on June
11, 2018, Chemtos, LLC, 14101 West Highway 290, Building 2000B, Austin,
Texas 78737 applied to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC)...... 1233 I
Cathinone............................... 1235 I
Methcathinone........................... 1237 I
4-Fluoro-N-methylcathinone (4-FMC)...... 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone)..............
Mephedrone (4-Methyl-N-methylcathinone). 1248 I
4-Methyl-N-ethylcathinone (4-MEC)....... 1249 I
Naphyrone............................... 1258 I
N-Ethylamphetamine...................... 1475 I
N,N-Dimethylamphetamine................. 1480 I
Fenethylline............................ 1503 I
Aminorex................................ 1585 I
4-Methylaminorex (cis isomer)........... 1590 I
Gamma Hydroxybutyric Acid............... 2010 I
Methaqualone............................ 2565 I
Mecloqualone............................ 2572 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole)...........
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl) indole)...........
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1- 7010 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide)................
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I
pentyl)1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone.......
AB-FUBINACA (N-(1-amino-3-methyl-1- 7012 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide)................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole). 7019 I
MDMB-FUBINACA (Methyl 2-(1-(4- 7020 I
fluorobenzyl)-1H-indazole-3-
carboxamido)-3,3-dimethylbutanoate)....
AB-PINACA (N-(1-amino-3-methyl-......... 7023 I
1-oxobutan-2-yl)-1-pentyl-1H-indazole-..
3-carboxamide)..........................
THJ-2201 [1-(5-fluoropentyl)-1H-indazol- 7024 I
3-.....................................
yl](naphthalen-1-yl)methanone...........
AB-CHMINACA (N-(1-amino-3-methyl-1-..... 7031 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-....
1H-indazole-3-carboxamide...............
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1- 7032 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide)................
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H- 7033 I
indazole-3-carboxamido)-3-
methylbutanoate).......................
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5- 7034 I
fluoropentyl)-1H-indazole-3-
carboxamido)-3,3-dimethylbutanoate)....
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide)...........................
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1- 7042 I
(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate)....
APINACA and AKB48 N-(1-Adamantyl)-1- 7048 I
pentyl-1H-indazole-3-carboxamide.......
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)- 7049 I
1-(5-fluoropentyl)-1H-indazole-3-
carboxamide)...........................
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole)..............
SR-19 (Also known as RCS-4) (1-Pentyl-3- 7104 I
[(4-methoxy)-benzoyl] indole...........
JWH-018 (also known as AM678) (1-Pentyl- 7118 I
3-(1-naphthoyl)indole).................
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl) indole).....................
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I
tetramethylcyclopropyl)methanone.......
JWH-073 (1-Butyl-3-(1-naphthoyl)indole). 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I
naphthoyl)indole)......................
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl) indole).....................
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole)............
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole- 7222 I
3-carboxylate).........................
5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I
fluoropentyl)-1H-indole-3-carboxylate).
Alpha-ethyltryptamine................... 7249 I
Ibogaine................................ 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I
[(1R,3S)-3-hydroxycyclohexyl-phenol)...
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol)..............
Lysergic acid diethylamide.............. 7315 I
2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine (2C-T-7)......
Marihuana Extract....................... 7350 I
Marihuana............................... 7360 I
Parahexyl............................... 7374 I
Mescaline............................... 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine (2C-T-2 )...................
3,4,5-Trimethoxyamphetamine............. 7390 I
4-Bromo-2,5-dimethoxyamphetamine........ 7391 I
[[Page 37522]]
4-Bromo-2,5-dimethoxyphenethylamine..... 7392 I
4-Methyl-2,5-dimethoxyamphetamine....... 7395 I
2,5-Dimethoxyamphetamine................ 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).....................
2,5-Dimethoxy-4-ethylamphetamine........ 7399 I
3,4-Methylenedioxyamphetamine........... 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine. 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine. 7402 I
3,4-Methylenedioxy-N-ethylamphetamine... 7404 I
3,4-Methylenedioxymethamphetamine....... 7405 I
4-Methoxyamphetamine.................... 7411 I
5-Methoxy-N-N-dimethyltryptamine........ 7431 I
Alpha-methyltryptamine.................. 7432 I
Bufotenine.............................. 7433 I
Diethyltryptamine....................... 7434 I
Dimethyltryptamine...................... 7435 I
Psilocybin.............................. 7437 I
Psilocyn................................ 7438 I
5-Methoxy-N,N-diisopropyltryptamine..... 7439 I
N-Ethyl-1-phenylcyclohexylamine......... 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine....... 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine... 7470 I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine.. 7473 I
N-Ethyl-3-piperidyl benzilate........... 7482 I
N-Methyl-3-piperidyl benzilate.......... 7484 I
N-Benzylpiperazine...................... 7493 I
4-Methyl-alphapyrrolidinopropiophenone 7498 I
(4-MePPP)..............................
2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine (2C-D)......................
2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine (2C-E ).....................
2-(2,5-Dimethoxyphenyl) ethanamine (2C- 7517 I
H).....................................
2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine (2C-I)......................
2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine (2C-C)......................
2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine (2C-N)......................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I
ethanamine (2C-P)......................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) 7532 I
ethanamine (2C-T-4 )...................
MDPV (3,4-Methylenedioxypyrovalerone)... 7535 I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- 7536 I
methoxybenzyl) ethanamine (25B-NBOMe)..
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- 7537 I
methoxybenzyl) ethanamine (25C-NBOMe)..
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I
methoxybenzyl) ethanamine (25I-NBOMe)..
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).......................
Butylone................................ 7541 I
Pentylone............................... 7542 I
alpha-pyrrolidinopentiophenone ([alpha]- 7545 I
PVP)...................................
alpha-pyrrolidinobutiophenone ([alpha]- 7546 I
PBP)...................................
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole)...................
Acetyldihydrocodeine.................... 9051 I
Benzylmorphine.......................... 9052 I
Codeine-N-oxide......................... 9053 I
Cyprenorphine........................... 9054 I
Desomorphine............................ 9055 I
Etorphine (except HCl).................. 9056 I
Codeine methylbromide................... 9070 I
Dihydromorphine......................... 9145 I
Difenoxin............................... 9168 I
Heroin.................................. 9200 I
Hydromorphinol.......................... 9301 I
Methyldesorphine........................ 9302 I
Methyldihydromorphine................... 9304 I
Morphine methylbromide.................. 9305 I
Morphine methylsulfonate................ 9306 I
Morphine-N-oxide........................ 9307 I
Myrophine............................... 9308 I
Nicocodeine............................. 9309 I
Nicomorphine............................ 9312 I
Normorphine............................. 9313 I
Pholcodine.............................. 9314 I
Thebacon................................ 9315 I
Acetorphine............................. 9319 I
Drotebanol.............................. 9335 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).......................
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]benzamid
e))....................................
Acetylmethadol.......................... 9601 I
Allylprodine............................ 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.....................
[[Page 37523]]
Alphameprodine.......................... 9604 I
Alphamethadol........................... 9605 I
Benzethidine............................ 9606 I
Betacetylmethadol....................... 9607 I
Betameprodine........................... 9608 I
Betamethadol............................ 9609 I
Betaprodine............................. 9611 I
Clonitazene............................. 9612 I
Dextromoramide.......................... 9613 I
Diampromide............................. 9615 I
Diethylthiambutene...................... 9616 I
Dimenoxadol............................. 9617 I
Dimepheptanol........................... 9618 I
Dimethylthiambutene..................... 9619 I
Dioxaphetyl butyrate.................... 9621 I
Dipipanone.............................. 9622 I
Ethylmethylthiambutene.................. 9623 I
Etonitazene............................. 9624 I
Etoxeridine............................. 9625 I
Furethidine............................. 9626 I
Hydroxypethidine........................ 9627 I
Ketobemidone............................ 9628 I
Levomoramide............................ 9629 I
Levophenacylmorphan..................... 9631 I
Morpheridine............................ 9632 I
Noracymethadol.......................... 9633 I
Norlevorphanol.......................... 9634 I
Normethadone............................ 9635 I
Norpipanone............................. 9636 I
Phenadoxone............................. 9637 I
Phenampromide........................... 9638 I
Phenoperidine........................... 9641 I
Piritramide............................. 9642 I
Proheptazine............................ 9643 I
Properidine............................. 9644 I
Racemoramide............................ 9645 I
Trimeperidine........................... 9646 I
Phenomorphan............................ 9647 I
Propiram................................ 9649 I
1-Methyl-4-phenyl-4-propionoxypiperidine 9661 I
1-(2-Phenylethyl)-4-phenyl-4- 9663 I
acetoxypiperidine......................
Tilidine................................ 9750 I
Acryl fentanyl (N-(1-phenethylpiperidin- 9811 I
4-yl)-N-phenylacrylamide)..............
Para-Fluorofentanyl..................... 9812 I
3-Methylfentanyl........................ 9813 I
Alpha-methylfentanyl.................... 9814 I
Acetyl-alpha-methylfentanyl............. 9815 I
Acetyl Fentanyl (N-(1-phenethylpiperidin- 9821 I
4-yl)-N-phenylacetamide)...............
Butyryl Fentanyl........................ 9822 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-phenethylpiperidin-4-
yl)isobutyramide)......................
Beta-hydroxyfentanyl.................... 9830 I
Beta-hydroxy-3-methylfentanyl........... 9831 I
Alpha-methylthiofentanyl................ 9832 I
3-Methylthiofentanyl.................... 9833 I
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-phenylfuran-
2-carboxamide).........................
Thiofentanyl............................ 9835 I
Beta-hydroxythiofentanyl................ 9836 I
Amphetamine............................. 1100 II
Methamphetamine......................... 1105 II
Lisdexamfetamine........................ 1205 II
Phenmetrazine........................... 1631 II
Methylphenidate......................... 1724 II
Amobarbital............................. 2125 II
Pentobarbital........................... 2270 II
Secobarbital............................ 2315 II
Glutethimide............................ 2550 II
Nabilone................................ 7379 II
1-Phenylcyclohexylamine................. 7460 II
Phencyclidine........................... 7471 II
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).................................
Phenylacetone........................... 8501 II
1-Piperidinocyclohexanecarbonitrile..... 8603 II
Alphaprodine............................ 9010 II
Anileridine............................. 9020 II
[[Page 37524]]
Cocaine................................. 9041 II
Codeine................................. 9050 II
Etorphine HCl........................... 9059 II
Dihydrocodeine.......................... 9120 II
Oxycodone............................... 9143 II
Hydromorphone........................... 9150 II
Diphenoxylate........................... 9170 II
Ecgonine................................ 9180 II
Ethylmorphine........................... 9190 II
Hydrocodone............................. 9193 II
Levomethorphan.......................... 9210 II
Levorphanol............................. 9220 II
Isomethadone............................ 9226 II
Meperidine.............................. 9230 II
Meperidine intermediate-A............... 9232 II
Meperidine intermediate-B............... 9233 II
Meperidine intermediate-C............... 9234 II
Methadone............................... 9250 II
Methadone intermediate.................. 9254 II
Metopon................................. 9260 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).................................
Morphine................................ 9300 II
Thebaine................................ 9333 II
Dihydroetorphine........................ 9334 II
Levo-alphacetylmethadol................. 9648 II
Oxymorphone............................. 9652 II
Noroxymorphone.......................... 9668 II
Phenazocine............................. 9715 II
Thiafentanil............................ 9729 II
Piminodine.............................. 9730 II
Racemethorphan.......................... 9732 II
Racemorphan............................. 9733 II
Alfentanil.............................. 9737 II
Remifentanil............................ 9739 II
Sufentanil.............................. 9740 II
Carfentanil............................. 9743 II
Tapentadol.............................. 9780 II
Bezitramide............................. 9800 II
Fentanyl................................ 9801 II
Moramide-intermediate................... 9802 II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances in bulk for distribution to its customers.
Dated: July 23, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-16468 Filed 7-31-18; 8:45 am]
BILLING CODE 4410-09-P
